Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials

BACKGROUND: The recent AFFIRM-AHF trial assessing the effect of intravenous (IV) iron on outcomes in patients hospitalised with worsening heart failure who had iron deficiency (ID) narrowly missed its primary efficacy endpoint of recurrent hospitalisations for heart failure (HHF) or cardiovascular (...

Descripción completa

Detalles Bibliográficos
Autores principales: Graham, Fraser J., Pellicori, Pierpaolo, Ford, Ian, Petrie, Mark C., Kalra, Paul R., Cleland, John G. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318946/
https://www.ncbi.nlm.nih.gov/pubmed/33755777
http://dx.doi.org/10.1007/s00392-021-01837-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318946/
https://www.ncbi.nlm.nih.gov/pubmed/33755777
http://dx.doi.org/10.1007/s00392-021-01837-8

Ejemplares similares